How Does Herlapsa 250mg Work

Herlapsa (Lapatinib 250mg) works as a targeted therapy for HER2-positive breast cancer by inhibiting the action of two key proteins, HER2 and EGFR, which are involved in the growth and survival of cancer cells. These proteins, when overexpressed, can lead to uncontrolled cancer cell growth.

Benefits of Herlapsa 250mg

Herlapsa 250mg offers significant benefits in the treatment of HER2-positive breast cancer, particularly in advanced or metastatic stages. By specifically targeting and inhibiting the HER2 and EGFR receptors, Herlapsa helps to slow down or stop the growth and spread of cancer cells.
Common Side Effects:

The most common side effects of Herlapsa 250mg are
• Diarrhea
• Nausea and vomiting
• Fatigue
• Skin rashes
• Loss of appetite
• Hand-foot syndrome (redness, swelling, and discomfort on palms and soles)
• Liver issues (elevated liver enzymes)
• Heart problems (QT interval prolongation)

Other side effects of Herlapsa 250mg can include
• Headache
• Abdominal pain
• Mouth sores or ulcers
• Dry mouth
• Dizziness
• Cough
• Shortness of breath
• Muscle or joint pain
• Swelling in the hands, feet, or ankles
• Changes in taste
• Fever
• Increased blood pressure

Who Should Not Take Herlapsa 250mg

Herlapsa 250mg should not be taken by individuals who are allergic to Lapatinib or any of the other ingredients in the medication. It is also contraindicated for pregnant women or those who are breastfeeding, as it may harm the unborn baby or pass into breast milk. Patients with severe liver problems, such as liver cirrhosis or hepatitis, should avoid taking Herlapsa, as the medication can further impair liver function.

How To Take Herlapsa 250mg

Herlapsa 250mg should be taken exactly as prescribed by your healthcare provider. It is typically taken once daily, and it is important to follow the instructions carefully. The tablet should be swallowed whole with a glass of water and should be taken on an empty stomach—either at least 1 hour before or 2 hours after a meal.